Status:
COMPLETED
The Use of Mobile Health Technology and Behavioral Economics to Encourage Adherence in Adolescents
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Wellth Inc.
MMAS-8 with permission from Dr Donald Morisky. as written below
Conditions:
Familial Hypercholesterolemia
Adherence, Medication
Eligibility:
All Genders
12-21 years
Phase:
NA
Brief Summary
Familial hypercholesterolemia (FH) affects over one million Americans and increases the risk of cardiovascular disease (CVD) by as much as 20-fold. Although the use of statins can substantially reduce...
Detailed Description
Preventing cardiovascular disease (CVD) in children and adolescents depend partly on the efficacy of the patients' self-management of their disease between clinic visits. One example of a health behav...
Eligibility Criteria
Inclusion
- Diagnosis of FH based on National Lipid Association (NLA) criteria and/or genetic testing
- Prescribed a statin
- Be able to provide written, informed consent or have a parent/guardian provide written, informed consent
- Be able to use a mobile phone and application
- Morisky Medication Adherence Scale score of ≤ 6
Exclusion
- Diagnosis of Homozygous FH
- Residence in a long-term care facility where medications are administered
- May become pregnant
- History of adverse effect or allergy to a statin, or any ingredient in a statin
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04458766
Start Date
January 1 2021
End Date
July 31 2024
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115